GLIMT THERAPEUTICS
Live / Applied — New application — not yet assigned to an examiner (as of 21 Jul 2026)
What this means for you
Not registered yet, but its 21 Jul 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50005381
- Mark type
- Word mark
- Filed
- 21 Jul 2026
- Attorney of record
- R. Peter Spies
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals; Biological preparations for use in industry and science
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of central nervous system [cns] diseases; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the treatment of inflammatory diseases; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of metabolic disorders; Pharmaceutical preparations for enzyme replacement therapy, all of the aforementioned products specifically excluding Ophthalmic preparations.
- Class 042 — Scientific and technological services: Research on the subject of pharmaceuticals; Pharmaceutical drug development services; Research and development of new products for others; Pharmaceutical research and development; Consulting services in the field of pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Scientific investigations for medical purposes; Research and development services in the field of medical preparations; Pharmaceutical research services; Medical research services; Pharmaceutical products development; Consulting services in the field of biotechnology; Research and development in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology
Owner
- Key2Brain AB, Solna, SE
Prosecution history
- 29 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 21 Jul 2026 — NEW APPLICATION ENTERED